Onzetra Xsail
Product Images NDC 42847-311

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Onzetra Xsail (NDC 42847-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Currax Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Onzetra 01)

Chemical structure of the active ingredient shown in the image, featuring a bicyclic indole core with substituted side chains including a methylsulfonyl group and a dimethylaminoethyl group, alongside a molecular fragment with two carboxylic acid groups, likely indicating a salt or co-crystal form.*

FDA Label Image

Figure 1 (Onzetra 02)

A line graph comparing the percentage of subjects with headache relief over time between ONZETRA 22 mg and placebo. The x-axis represents minutes post dose (0 to 120), and the y-axis shows percentage of subjects with headache relief (0 to 100%). ONZETRA shows a higher percentage of relief at all measured times with notable differences marked by asterisks, indicating statistical significance (p<0.05).*

FDA Label Image

Figure (Onzetra 03)

Instructional diagram showing how to use Onzetra Xsail. Part 1 guides inserting the first nosepiece into the 1st nostril, pressing and releasing the white button to pierce the capsule, inserting the nosepiece into the nose, rotating the device to place the mouthpiece in the mouth, and blowing into the device for 2-3 seconds. Part 2 instructs removing the first nosepiece, checking the capsule, inserting the second nosepiece into the 2nd nostril, and repeating pressing and blowing steps. Warnings emphasize not pressing the white button while blowing. A checklist confirms correct use, illustrated with images of unused and used capsules.*

FDA Label Image

Principal Display Panel (11 mg Pouch Carton)

Onzetra Xsail (sumatriptan nasal powder) 11 mg per nosepiece packaging label from Currax Pharmaceuticals LLC. The label highlights it as a prescription intranasal medication delivered via a breath-powered system. The packaging includes usage instructions, handling information, contents details, and warnings to keep out of reach of children. The box features images of the nasal delivery device and mentions the product's NDC 42847-311-08.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.